During the past ten years, a comprehensive sickle cell program has emerged at the University of south Alabama. Since the grant award from the National Heart, Lung and Blood Institute in 1988, the center has developed exponentially. The goal of the Comprehensive Sickle Cell Center is to improve the lives of sickle cell patients in the region as well as in the international community. The region of the central Gulf Coast has a large population at risk of sickle cell disorders. The goal of improving the lives of sickle cell patients is being accomplished through (i) basic, clinical and applied research to understand the pathophysiology, diagnosis and management of sickle cell disease; (ii) education of health professionals, patients and their families, and community at large; (iii) clinical and laboratory diagnosis of sickle cell disease and its complications as well as carrier state, pre-natal diagnosis, newborn screening and follow-up; and (iv) counseling, both genetic and psychosocial. The objectives of basic research projects are to elucidate the mechanism of hemoglobin switch through cloning of transacting regulatory gene(s) and studies of a 70 Kd, DNA-binding protein; to study interactions of spectrin, actin and band 4.1 cytoskeletal proteins; to determine the role of a newly described cytoplasmic protein, Calpromotin, in dehydration of sickle cells and the role of oxidation in sickle erythrocyte membrane damage; to examine interaction of blood cells and adhesion-influencing molecules; and to investigate the mechanism of microvascular injury in lungs. The clinical research projects evaluate school readiness in young children with sickle cell disease, and the impact of comprehensive health care on quality of life of the patients and health care costs. A strong community program provides counseling and supportive services. In summary, the University of South Alabama Comprehensive Sickle Cell Center proposes to continue research, diagnosis, education, and counseling to improve the lives of those who have sickle cell disease.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Comprehensive Center (P60)
Project #
5P60HL038639-08
Application #
2218963
Study Section
Special Emphasis Panel (SRC (SH))
Project Start
1988-04-01
Project End
1998-03-31
Budget Start
1995-04-01
Budget End
1996-03-31
Support Year
8
Fiscal Year
1995
Total Cost
Indirect Cost
Name
University of South Alabama
Department
Pediatrics
Type
Schools of Medicine
DUNS #
City
Mobile
State
AL
Country
United States
Zip Code
36688
Pace, B S; Qian, X; Ofori-Acquah, S F (2004) Selective inhibition of beta-globin RNA transcripts by antisense RNA molecules. Cell Mol Biol (Noisy-le-grand) 50:43-51
Haynes Jr, Johnson; Baliga, B Surendra; Obiako, Boniface et al. (2004) Zileuton induces hemoglobin F synthesis in erythroid progenitors: role of the L-arginine-nitric oxide signaling pathway. Blood 103:3945-50
Haynes Jr, Johnson; Obiako, Boniface (2002) Activated polymorphonuclear cells increase sickle red blood cell retention in lung: role of phospholipids. Am J Physiol Heart Circ Physiol 282:H122-30
Foley, Heather A; Ofori-Acquah, Solomon F; Yoshimura, Akihiko et al. (2002) Stat3 beta inhibits gamma-globin gene expression in erythroid cells. J Biol Chem 277:16211-9
Abraham, Ann; Bencsath, F Aladar; Shartava, Archil et al. (2002) Preparation of irreversibly sickled cell beta-actin from normal red blood cell beta-actin. Biochemistry 41:292-6
Kakhniashvili, D G; Goodman, S R (2001) Isolation of spectrin subunits by reverse-phase high-performance liquid chromatography. Protein Expr Purif 23:249-51
Sangerman, J; Kakhniashvili, D; Brown, A et al. (2001) Spectrin ubiquitination and oxidative stress: potential roles in blood and neurological disorders. Cell Mol Biol Lett 6:607-36
Yang, Y M; Pace, B (2001) Pharmacologic induction of fetal hemoglobin synthesis: cellular and molecular mechanisms. Pediatr Pathol Mol Med 20:87-106
Cepeda, M L; Allen, F H; Cepeda, N J et al. (2000) Physical growth, sexual maturation, body image and sickle cell disease. J Natl Med Assoc 92:4-Oct
Xu, L; Ferry, A E; Monteiro, C et al. (2000) Beta globin gene inhibition by antisense RNA transcripts. Gene Ther 7:438-44

Showing the most recent 10 out of 54 publications